[go: up one dir, main page]

PT1761553E - Peptídeos associados a tumores de ligação à molécula mhc - Google Patents

Peptídeos associados a tumores de ligação à molécula mhc Download PDF

Info

Publication number
PT1761553E
PT1761553E PT05752606T PT05752606T PT1761553E PT 1761553 E PT1761553 E PT 1761553E PT 05752606 T PT05752606 T PT 05752606T PT 05752606 T PT05752606 T PT 05752606T PT 1761553 E PT1761553 E PT 1761553E
Authority
PT
Portugal
Prior art keywords
amino acid
mhc
tumor
given
peptide
Prior art date
Application number
PT05752606T
Other languages
English (en)
Inventor
Hans-Georg Rammensee
Toni Weinschenk
Claudia Lemmel
Stefan Stevanovic
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of PT1761553E publication Critical patent/PT1761553E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT05752606T 2004-05-25 2005-05-24 Peptídeos associados a tumores de ligação à molécula mhc PT1761553E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004026135A DE102004026135A1 (de) 2004-05-25 2004-05-25 An MHC-Moleküle bindende Tumor-assoziierte Peptide

Publications (1)

Publication Number Publication Date
PT1761553E true PT1761553E (pt) 2009-12-22

Family

ID=34970615

Family Applications (2)

Application Number Title Priority Date Filing Date
PT09000315T PT2058323E (pt) 2004-05-25 2005-05-24 Peptídeos associados a tumores de ligação à molécula mhc
PT05752606T PT1761553E (pt) 2004-05-25 2005-05-24 Peptídeos associados a tumores de ligação à molécula mhc

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT09000315T PT2058323E (pt) 2004-05-25 2005-05-24 Peptídeos associados a tumores de ligação à molécula mhc

Country Status (14)

Country Link
US (2) US8008431B2 (pt)
EP (2) EP1761553B1 (pt)
JP (2) JP4764874B2 (pt)
AT (1) ATE446310T1 (pt)
AU (1) AU2005247598B2 (pt)
CA (2) CA2568254C (pt)
CY (2) CY1109672T1 (pt)
DE (2) DE102004026135A1 (pt)
DK (2) DK2058323T3 (pt)
ES (2) ES2333804T3 (pt)
PL (2) PL1761553T3 (pt)
PT (2) PT2058323E (pt)
SI (2) SI2058323T1 (pt)
WO (1) WO2005116051A2 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004213A1 (en) * 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
WO2009003493A2 (en) 2007-07-03 2009-01-08 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
AU2012216641B2 (en) * 2007-07-27 2015-02-05 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
RS54204B1 (sr) * 2007-07-27 2015-12-31 Immatics Biotechnologies Gmbh Nova imunoterapija protiv tumora mozga
MX2010001090A (es) * 2007-07-27 2010-04-07 Immatics Biotechnologies Gmbh Nuevos epitopos inmunogenicos para inmunoterapia.
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
WO2009054470A1 (ja) * 2007-10-25 2009-04-30 Toray Industries, Inc. 免疫誘導剤及びその用途
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
RS54374B1 (sr) * 2008-03-27 2016-04-28 Immatics Biotechnologies Gmbh Nova imunoterapija protiv tumora nervnih ćelija i mozga
DK2113253T3 (da) * 2008-04-30 2010-07-19 Immatics Biotechnologies Gmbh Ny sammensætning af tumorassocierede peptider, der bindes til humant leukocyt-antigen (HLA) klasse I eller II molekyler, til vaccinebrug
SI2119726T2 (en) * 2008-05-14 2018-03-30 Immatics Biotechnologies Gmbh New and powerful Class II MHC peptides derived from survivin and neurocane
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
BRPI0911925B8 (pt) * 2008-08-05 2024-02-06 Toray Industries Método para detectar um câncer
ES2619322T3 (es) 2008-08-05 2017-06-26 Toray Industries, Inc. Agente inductor de inmunidad
CN102170907A (zh) 2008-08-05 2011-08-31 东丽株式会社 用于治疗和预防癌症的药物组合物
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
AU2016204708B2 (en) * 2008-10-01 2018-02-22 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors including neuronal and brain tumors
RS53782B1 (sr) 2008-10-01 2015-06-30 Immatics Biotechnologies Gmbh Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010117010A1 (ja) 2009-04-10 2010-10-14 北海道公立大学法人札幌医科大学 腫瘍マーカーおよびその利用
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
JP5845899B2 (ja) 2010-02-04 2016-01-20 東レ株式会社 癌の治療及び／又は予防用医薬組成物
PL2532743T3 (pl) 2010-02-04 2015-09-30 Toray Industries Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka
EP2532366B1 (en) 2010-02-04 2016-09-07 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
JP5742714B2 (ja) 2010-02-04 2015-07-01 東レ株式会社 癌の治療及び／又は予防用医薬組成物
MX2012008991A (es) 2010-02-04 2012-09-07 Toray Industries Medicamento para tratar y/o prevenir el cancer.
ES2583777T3 (es) 2010-02-04 2016-09-22 Toray Industries, Inc. Composición farmacéutica que comprende anticuerpos anti CAPRIN-1 para el tratamiento y/o la prevención del cáncer
GB201009222D0 (en) * 2010-06-02 2010-07-21 Immatics Biotechnologies Gmbh Improved cancer therapy based on tumour associated antigens derived from cyclin D1
IT1400874B1 (it) * 2010-07-05 2013-07-02 Univ Degli Studi Genova Supporto planare avente una superficie ultrapiatta e dispositivo per la rivelazione di antigeni comprendente detto supporto planare.
MY170949A (en) * 2011-07-11 2019-09-20 Cancer Res Initiatives Foundation A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine
WO2013125636A1 (ja) 2012-02-21 2013-08-29 東レ株式会社 癌の治療及び／又は予防用医薬組成物
DE102012105193B4 (de) * 2012-06-15 2014-04-03 Eberhard-Karls-Universität Tübingen Universitätsklinikum Stimulation der zellulären Immunantwort gegen das Epstein-Barr-Virus (EBV)
CN104497123B (zh) * 2013-12-23 2017-10-27 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
CN104497125B (zh) * 2013-12-23 2018-04-27 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
CN104497124B (zh) * 2013-12-23 2017-10-03 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
GB201505585D0 (en) * 2015-03-31 2015-05-13 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
MA42294B1 (fr) 2015-07-01 2020-11-30 Immatics Biotechnologies Gmbh Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
GB201512369D0 (en) * 2015-07-15 2015-08-19 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
GB201512733D0 (en) * 2015-07-20 2015-08-26 Genagon Therapeutics Ab Therapeutic agents for treating conditions associated with elevated GDF15
CN105859865B (zh) * 2016-05-05 2019-07-05 南方医科大学 一种基于Eps8-EGFR结合域的双重抗肿瘤多肽
CN106645677B (zh) * 2016-11-15 2019-08-09 恒瑞源正（上海）生物科技有限公司 体外检测肿瘤新生抗原特异性t细胞的方法、试剂盒以及肿瘤疫苗
KR102379955B1 (ko) 2016-12-08 2022-03-29 이매틱스 바이오테크놀로지스 게엠베하 짝짓기가 향상된 t 세포 수용체
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
GB201700567D0 (en) 2017-01-12 2017-03-01 Genagon Therapeutics Ab Therapeutic agents
WO2020127222A2 (en) 2018-12-17 2020-06-25 Immudex Aps Panel comprising borrelia mhc multimers
CN114207675A (zh) 2019-05-28 2022-03-18 佩治人工智能公司 用于数字病理学的用于处理图像以针对所处理的图像制备载片的系统和方法
WO2022125504A1 (en) * 2020-12-07 2022-06-16 Iogenetics, Llc Bystander protein vaccines
EP4484442A1 (en) * 2023-06-29 2025-01-01 Uniwersytet Gdanski Tissue extracellular peptide patterns dedicated for generation of anti-cancer vaccines against salivary gland tumor, identification and isolation of salivary gland tumor specific t cells in humans

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5955314A (en) * 1996-11-08 1999-09-21 Incyte Pharmaceuticals, Inc. Regulator of cell signaling
US6255055B1 (en) * 1998-03-09 2001-07-03 Wisconsin Alumni Research Foundation c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence
US7198920B1 (en) * 1999-01-29 2007-04-03 Corika Corporation HER-2/neu fusion proteins
US6274362B1 (en) * 1999-02-04 2001-08-14 Millennium Pharmaceuticals, Inc. RGS-containing molecules and uses thereof
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
JP4097178B2 (ja) * 2000-10-03 2008-06-11 株式会社グリーンペプタイド 腫瘍抗原
US7009040B2 (en) * 2003-01-21 2006-03-07 Arius Research, Inc. Cancerous disease modifying antibodies
AU2002246998A1 (en) * 2001-01-18 2002-07-30 Human Genome Sciences, Inc. 50 human secreted proteins
US20040236091A1 (en) * 2001-03-28 2004-11-25 Chicz Roman M. Translational profiling
DE10225144A1 (de) * 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
WO2004015390A2 (en) * 2002-08-09 2004-02-19 Applera Corporation Lung cancer target proteins and use thereof
JP2006516089A (ja) * 2002-10-02 2006-06-22 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
JP2006501827A (ja) * 2002-10-03 2006-01-19 エピミューン インコーポレイテッド 最適化されたマルチエピトープ構築体及びその使用
US7468254B2 (en) * 2003-01-21 2008-12-23 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP

Also Published As

Publication number Publication date
US20100029573A1 (en) 2010-02-04
AU2011202473A1 (en) 2011-06-16
CY1112984T1 (el) 2016-04-13
CA2777821A1 (en) 2005-12-08
CA2568254A1 (en) 2005-12-08
JP2011224007A (ja) 2011-11-10
AU2005247598A1 (en) 2005-12-08
ES2385532T3 (es) 2012-07-26
US8008431B2 (en) 2011-08-30
EP2058323B1 (de) 2012-05-16
ATE446310T1 (de) 2009-11-15
US20100021441A1 (en) 2010-01-28
SI1761553T1 (sl) 2010-01-29
WO2005116051A2 (de) 2005-12-08
DK2058323T3 (da) 2012-08-06
PT2058323E (pt) 2012-07-10
CA2568254C (en) 2016-04-19
JP2008500033A (ja) 2008-01-10
SI2058323T1 (sl) 2012-08-31
DE502005008379D1 (de) 2009-12-03
PL1761553T3 (pl) 2010-07-30
EP1761553A2 (de) 2007-03-14
DK1761553T3 (da) 2010-02-01
JP4764874B2 (ja) 2011-09-07
CY1109672T1 (el) 2014-08-13
EP2058323A1 (de) 2009-05-13
JP5182770B2 (ja) 2013-04-17
ES2333804T3 (es) 2010-03-01
DE102004026135A1 (de) 2006-01-05
AU2005247598B2 (en) 2011-06-02
CA2777821C (en) 2015-09-22
US8242239B2 (en) 2012-08-14
EP1761553B1 (de) 2009-10-21
PL2058323T3 (pl) 2012-09-28
WO2005116051A3 (de) 2006-03-02

Similar Documents

Publication Publication Date Title
PL1761553T3 (pl) Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC
He et al. Facile synthesis of site-specifically acetylated and methylated histone proteins: reagents for evaluation of the histone code hypothesis
UA98295C2 (ru) Опухолево-ассоциированный пептид, который неспецифически связывается с молекулами ii класса лейкоцитарного антигена человека (hla)
IL186802A0 (en) Oxyntomodulin analogues and compositions containing the same
WO2009004054A3 (en) A cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide
MXPA06003474A (es) Agonistas de receptores de melanocortina.
MXPA04008077A (es) Anticuerpos ant-a° y su uso.
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
NO20063026L (no) Antistoffer
MY149128A (en) A method for the mass production of immunoglobulin fc region deleted initial methionine residues
JP2005520490A5 (pt)
EP1801206A4 (en) PROCESS FOR THE PREPARATION OF L-ARGININE, L-ORNITHIN OR L-CITRULLINE
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
SI1551977T1 (sl) Selektivno lokalno aktiviranje članov TNF ligandske družine sistemsko inaktivnih neprotitelesnih TNF ligandskih fuzijskih proteinov
WO2005079523A3 (en) Novel teleost derived antimicrobal polypeptides
IL173969A0 (en) Use of peptides derived from the a alpha or b beta chain of human of human fibrinogen for the treatment of shock
WO2004085461A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
EP1842911A4 (en) HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS
WO2006075253A3 (en) Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
EP1757687A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
EP1568775A4 (en) CANCER ASSOCIATED GEN